Teva and Active Biotech hit by Phase 3 drug failure
May 8, 2017Research and Development, Sales and Marketing Active Biotech, Teva
Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …
Weight loss pill treatment rejected by NICE
May 8, 2017Medical Communications, Sales and Marketing NICE, orexigen
NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …
Board battle scuppers Seattle Genetics’ $2 billion licensing deal
May 8, 2017Sales and Marketing Immunomedics, Seattle Genetics, venBio
In another example of the influence that activist investors can have on the direction of a business, the potentially $2 …
NHS staff feeling the pay squeeze, reports NHS Providers
May 8, 2017Medical Communications, Sales and Marketing NHS, NHS Providers
NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …
FDA approves first new treatment for ALS in two decades
May 8, 2017Sales and Marketing MLS, Mitsubishi Tanabe Pharma America, Radicava
The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …
Top Ten most popular articles on Pharmafile.com this week
May 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …
Pfizer offers breast cancer drug for free following NICE rejection
May 5, 2017Medical Communications, Sales and Marketing NICE, Pfizer
Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …
Regulus CEO heads to exit as company struggles with FDA hold
May 5, 2017Medical Communications, Research and Development Regulus, hepatitis C
Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …
J&J chalks up another defeat in $110 million talc-cancer case
May 5, 2017Medical Communications Johnson & Johnson, baby powder
Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …
GSK boosts Benlysta production with $139 million investment
May 5, 2017Manufacturing and Production, Medical Communications GSK
GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …
‘Exercise pill’ boosts endurance by 70% in mice
May 4, 2017Research and Development
A study by the Salk Institute found that mice that were given a chemical compound, named GW1517 (GW), were able …
European Commission warns UK over drug authorisation validity due to Brexit
May 4, 2017Medical Communications, Sales and Marketing EMA, European Commission, brexit
The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …
WHO aims to increase uptake of biosimilars in poorer countries
May 4, 2017Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars
The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …
Roche denies its acne treatment led to suicide of 21 year old
May 4, 2017Medical Communications, Sales and Marketing Roaccutane, Roche
Last month, Luke Reeves took his own life at the age of just 21. Prior to his death, he had …
Cheap blood test may help tailor prostate cancer treatment
May 4, 2017Research and Development Blood test, prostate cancer
A blood test that costs less than £50 to perform could prevent men from undergoing treatment with two drugs that …
Real-world data: High on the life science agenda
May 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing real world data, real-world data
John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences …
Researchers identify key trigger in melanoma progression
May 3, 2017Research and Development melanoma
Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French National Institute …
Study discovers origin of cancer metastases and why they reoccur
May 3, 2017Research and Development Cancer, metastases
A team of scientists from The Scripps Research Institute (TSRI) have discovered the secrets of where metastases originate and why …
First large-scale study gives hope for ketamine as a depression therapy
May 3, 2017Research and Development Ketamine, depression, mental health
While the development of truly innovative mental health therapies has ground to a halt somewhat, scientific research in the field …
NICE recommends Janssen’s first-of-its-kind Crohn’s drug Stelara
May 3, 2017Research and Development, Sales and Marketing Crohn’s disease, Janssen, NICE, Stelara, crohn's disease
Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the indication of moderately to severely …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
